Anti-Fungal Drugs Market 2020 By Industry Size Estimation, Industry Share, Future Demand, Dynamics, Drivers, Research Methodology By 2027

Anti-Fungal Drugs Market 2020 By Industry Size Estimation, Industry Share, Future Demand, Dynamics, Drivers, Research Methodology By 2027


The global anti-fungal drugs market size is likely to reach USD 13.17 billion by 2027 on account of the increasing prevalence of skin infections worldwide. Mycosis or fungal infection is a skin disease caused by a group of spore-producing organisms living and feeding on the human skin. When untreated, they lead to skin issues such as rashes, athlete’s foot, yeast infection, ringworm, nail fungus, bumps, and others. According to a recently published report by Fortune Business Insights™ titled, “Anti-Fungal Drugs Market Size, Share & Industry Analysis, By Drug Type (Echinocandins, Azoles, Polyenes, and Allylamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis, and Others), By Route of Administration (Oral, Topical, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Stores, and Others), and Regional Forecast, 2020-2027,” the market value was USD 10.24 billion in 2019, and will exhibit a CAGR of 3.3% between 2020 and 2027.


Please visit: https://www.fortunebusinessinsights.com/industry-reports/antifungal-drugs-market-101188

 

Detailed Table of Content:

 

1.       Introduction

1.1.    Research Scope

1.2.    Market Segmentation

1.3.    Research Methodology

1.4.    Definitions and Assumptions

2.       Executive Summary

3.       Market Dynamics

3.1.    Market Drivers

3.2.    Market Restraints

3.3.    Market Opportunities

4.       Key Insights

4.1.    Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)

4.2.    Prevalence of Fungal Infections

4.3.    Pipeline Analysis

4.4.    New Product Launches

5.       Global Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027

5.1.    Key Findings / Summary

5.2.    Market Analysis, Insights and Forecast – By Drug Type

5.2.1. Azoles

5.2.2. Echinocandins

5.2.3. Polyenes

5.2.4. Allylamines

5.3.    Market Analysis, Insights and Forecast – By Indication

5.3.1. Dermatophytosis

5.3.2. Candidiasis

5.3.3. Aspergillosis

5.3.4. Others

5.4.    Market Analysis, Insights and Forecast – By Route of Administration

5.4.1. Oral

5.4.2. Topical

5.4.3. Parenteral

5.5.    Market Analysis, Insights and Forecast – By Distribution Channel

5.5.1. Hospitals Pharmacies

5.5.2. Retail Pharmacies & Drug Stores

5.5.3. Online Pharmacies

5.6.    Market Analysis, Insights and Forecast – By Region

5.6.1. North America

5.6.2. Europe

5.6.3. Asia pacific

5.6.4. Latin America

5.6.5. Middle East & Africa

6.       North America Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027

6.1.    Key Findings / Summary

6.2.    Market Analysis – By Drug Type

6.2.1. Azoles

6.2.2. Echinocandins

6.2.3. Polyenes

6.2.4. Allylamines

6.3.    Market Analysis – By Indication

6.3.1. Dermatophytosis

6.3.2. Candidiasis

6.3.3. Aspergillosis

6.3.4. Others

6.4.    Market Analysis – By Route of Administration

6.4.1. Oral

6.4.2. Topical

6.4.3. Parenteral

6.5.    Market Analysis – By Distribution Channel

6.5.1. Hospitals Pharmacies

6.5.2. Retail Pharmacies & Drug Stores

6.5.3. Online Pharmacies

6.6.    Market Analysis – By Country

6.6.1. U.S.

6.6.2. Canada

7.       Europe Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027

7.1.    Key Findings / Summary

7.2.    Market Analysis – By Drug Type

7.2.1. Azoles

7.2.2. Echinocandins

7.2.3. Polyenes

7.2.4. Allylamines

7.3.    Market Analysis – By Indication

7.3.1. Dermatophytosis

7.3.2. Candidiasis

7.3.3. Aspergillosis

7.3.4. Others

7.4.    Market Analysis – By Route of Administration

7.4.1. Oral

7.4.2. Topical

7.4.3. Parenteral

7.5.    Market Analysis – By Distribution Channel

7.5.1. Hospitals Pharmacies

7.5.2. Retail Pharmacies & Drug Stores

7.5.3. Online Pharmacies

7.6.    Market Analysis – By Country/ sub-region

7.6.1. U.K.

7.6.2. Germany

7.6.3. France

7.6.4. Spain

7.6.5. Italy

7.6.6. Scandinavia

7.6.7. Rest of Europe

8.       Asia pacific Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027

8.1.    Key Findings / Summary

8.2.    Market Analysis – By Drug Type

8.2.1. Azoles

8.2.2. Echinocandins

8.2.3. Polyenes

8.2.4. Allylamines

8.3.    Market Analysis – By Indication

8.3.1. Dermatophytosis

8.3.2. Candidiasis

8.3.3. Aspergillosis

8.3.4. Others

8.4.    Market Analysis – By Route of Administration

8.4.1. Oral

8.4.2. Topical

8.4.3. Parenteral

8.5.    Market Analysis – By Distribution Channel

8.5.1. Hospitals Pharmacies

8.5.2. Retail Pharmacies & Drug Stores

8.5.3. Online Pharmacies

8.6.    Market Analysis – By Country/ sub-region

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. Australia

8.6.5. Southeast Asia

8.6.6. Rest of Asia Pacific